BH-29 - ABCs: Antimicrobial Business Case for the C-Suite on OPAT

Wednesday, October 22, 2025

8:30 AM - 8:55 AM US ET

Location: BugHub World Stage

CME Credits: Maximum of 0 hours of AMA PRA Category 1 Credit™
MOC Credits: Maximum of 0 hours of MOC Credit
CNE Credits: Maximum of 0 hours of ANCC Credit
ACPE Credits: ACPE 0 knowledge-based contact hours of pharmacy CE
ACPE Number: JA0007082-9999-24-002-L01-P
PACE Credits: Maximum of 0 of PACE contact hours
CE Broker: Maximum of 0 CE broker credit hours

Presenter(s)

Pranavi Sreeramoju, MD, MPH, MBA, FIDSA, FSHEA (she/her/hers)

Associate Professor
University of Pennsylvania Perelman School of Medicine
Philadelphia, PA, United States
MM

Monica Mahoney, PharmD, BCPS, BCIDP, FCCP, FIDSA, FIDP, FMSHP (she/her/hers)

Clinical Pharmacy Specialist, Ambulatory/Infectious Diseases
Beth Israel Deaconess Medical Center
Boston, MA, United States
JN

Jerod Nagel, PharmD

Pharmacist
Michigan Medicine
Ann Arbor, Michigan, United States
CS

Cheryl Smith

IDSA
ARLINGTON, Virginia, United States

Disclosure(s):

Monica V. Mahoney, PharmD, BCPS, BCIDP, FCCP, FIDSA, FIDP, FMSHP: CSL Seqirus: Advisor/Consultant; GSK: Advisor/Consultant

Cheryl Smith: No financial relationships to disclose.